INS and metabolic syndrome: A study by Setola et al. [65] demonstrated that folate and B12 treatment in patients with MetS improved resistance to insulin and endothelial dysfunction as well as decreased tHcy levels, suggesting the beneficial effects of these vitamins on CVD risk factors.